Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.
A 62-year-old woman developed symptoms of polymyalgia rheumatica (PMR), but without clinical evidence of concomitant giant cell arteritis (GCA). A single blind, placebo-controlled trial of prednisolone confirmed the diagnosis, but in addition unwittingly exposed clinically silent giant cell arteritis.
D004334:Drug Administration Schedule; D005260:Female; D013700:Giant Cell Arteritis / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D011111:Polymyalgia Rheumatica / Q000188:drug therapy*; D011239:Prednisolone / Q000009:adverse effects* / Q000627:therapeutic use
D011239:Prednisolone